The Mounjaro starter dose: why 2.5mg exists and what happens next

Why the 2.5mg dose exists at all

Tirzepatide slows gastric emptying and reduces appetite through two gut-hormone pathways, GIP and GLP-1 receptors. Both effects are real from the first injection, and both can produce nausea, vomiting or loose stools if the body meets full therapeutic doses without warning. If you want to understand more about why things are structured this way, our page on the tirzepatide starter dose explains how 2.5mg is calibrated to introduce those effects gently. It is the lowest of six available strengths (2.5, 5, 7.5, 10, 12.5 and 15mg), and the NHS tirzepatide page is clear that this initial dose is chosen for tolerability rather than weight loss.

Most of the weight loss in clinical trials happened as doses climbed, the SURMOUNT-1 trial, which followed adults on tirzepatide for 72 weeks, saw average body-weight reductions of around 20–21% at the 15mg maintenance dose. That outcome sits at the end of a stepwise process that begins exactly where you are now: week one, 2.5mg, waiting to see how your system responds.

It is also worth knowing that the starter dose does not predict how well you will ultimately do. People who find 2.5mg uneventful and people who find it queasy can both go on to see meaningful results at higher doses. The first four weeks are adjustment, not audition.

What happens after the starter dose, and who decides

Our page on the Mounjaro starting dose covers how, after four weeks at 2.5mg, the standard next step is 5mg. From there, each dose level typically runs for another four weeks before the prescriber considers moving you up again. The ceiling is 15mg, but plenty of people find an earlier dose that suits them and stay there. Nothing in the licensed schedule says you must reach 15mg.

The decision at each rung belongs to the prescriber, not to you. That is not a bureaucratic quirk, it reflects the fact that tolerance, response and any side effects need professional eyes on them before each increase. At nume, a GPhC-registered Independent Prescriber reviews the clinical picture before every repeat order, including before any dose change. There is no automated approval; a real clinician reads your answers and your progress data.

If you have seen the question come up about starting at 5mg rather than 2.5mg, our guide on what dose of Mounjaro you start on explains that the licence and the SmPC specify 2.5mg as the entry point for everyone. Jumping ahead is not standard practice and would need a strong clinical reason.

Side effects at the starter dose: what is normal and what is not

Mild nausea is the most commonly reported experience in the first few weeks. Some people also notice slower digestion, a feeling of fullness on smaller amounts of food, or occasional loose stools. These effects tend to be most noticeable in the 24–48 hours after an injection and generally settle within a week or two of starting a new dose level. Eating smaller portions, avoiding very fatty meals and staying hydrated all help.

The side effects worth paying attention to are different in character: severe, persistent abdominal pain that radiates to the back (potentially a sign of pancreatitis) warrants urgent medical attention. The MHRA issued a Drug Safety Update in January 2026 reinforcing this point for GLP-1 medicines as a class. If something feels seriously wrong rather than mildly uncomfortable, the right move is to contact a healthcare professional, not to wait for it to pass. You can also report suspected reactions at the MHRA's Yellow Card scheme.

For a fuller picture of how Mounjaro works and what monitoring to expect, our main Mounjaro page covers the broader clinical landscape.

The cost question and where the starter dose fits into it

People sometimes ask whether it is cheaper to stay on the 2.5mg starter dose indefinitely. It is a reasonable thought, given that Mounjaro's UK list price rose significantly from September 2025 and private monthly costs vary by dose. You can see a plain breakdown of what drives those figures on our Mounjaro cost page. The practical answer is that 2.5mg is not a long-term prescription in its own right, it is the entry point on a clinical programme, and prescribers review whether continuing on any dose remains appropriate at every stage.

If you are still working out whether Mounjaro is the right route for you at all, the weight-loss treatments overview sets out the landscape of licensed options clearly. And if you are ready to find out whether you are clinically suitable, the most straightforward next step is to check your eligibility with a free consultation, reviewed the same day by one of our prescribers, usually before the afternoon post goes.